ICLR Insider Trading Activity

Transactions disclosed by company insiders to the SEC on Form 4, most recent first.

InsiderRoleDateSharesValue
McCague Eugene Pacelli Director 2026-08-11 88 $14,319
McCague Eugene Pacelli Director 2026-08-11 96 $15,722
McCague Eugene Pacelli Director 2026-08-11 590 $97,037
McCague Eugene Pacelli Director 2026-08-11 67 $11,089
Murphy Ronan Martin Director 2026-08-11 88 $14,319
Murphy Ronan Martin Director 2026-08-11 96 $15,722
Murphy Ronan Martin Director 2026-08-11 590 $97,037
Murphy Ronan Martin Director 2026-08-11 67 $11,089
Murray Ciaran Director 2026-08-11 280 $45,562
Murray Ciaran Director 2026-08-11 305 $49,950

How Institutional Funds Moved on ICLR

Position changes disclosed in SEC Form 13F filings. These report a quarterly snapshot, not exact trade dates.

FundChangeQuarter
LYRICAL ASSET MANAGEMENT LP LYRICAL ASSET MANAGEMENT LP increased this position by 47% ($103,821,655 -> $153,069,604). 2026-06-30
AMERIPRISE FINANCIAL INC AMERIPRISE FINANCIAL INC increased this position by 1777% ($8,277,810 -> $155,383,401). 2026-06-30
Sachem Head Capital Management LP Sachem Head Capital Management LP exited a position previously worth $232,939,300. 2026-06-30
Holocene Advisors, LP Holocene Advisors, LP exited a position previously worth $93,047,908. 2026-06-30
Impactive Capital LP Impactive Capital LP exited a position previously worth $49,856,756. 2026-06-30
Madison Avenue Partners, LP Madison Avenue Partners, LP exited a position previously worth $141,958,853. 2026-06-30
MARSHALL WACE, LLP MARSHALL WACE, LLP increased this position by 1559% ($1,589,852 -> $26,371,089). 2026-06-30
Soleus Capital Management, L.P. Soleus Capital Management, L.P. exited a position previously worth $21,246,720. 2026-06-30

Which Funds Hold ICLR

Largest reported positions as of 2026-06-30.

FundValueShares
AMERIPRISE FINANCIAL INC $155,383,401 894,496
LYRICAL ASSET MANAGEMENT LP $153,069,604 881,179
HUDSON EDGE INVESTMENT PARTNERS INC. $63,660,720 366,477
Diamond Hill Capital Management, LLC (Investment Advisor) $33,807,093 194,618
MARSHALL WACE, LLP $26,371,089 151,811
NEW YORK STATE COMMON RETIREMENT FUND $21,356,429 122,943
GEODE CAPITAL MANAGEMENT, LLC $17,134,580 98,639
Distillate Capital Partners LLC $15,064,131 86,720
Leith Wheeler Investment Counsel Ltd. $13,166,180 75,794
Allianz Asset Management GmbH $7,717,414 44,427

Data compiled from public SEC filings. This is informational reporting, not investment advice.

Soleus Capital Management, L.P.: 13F Portfolio Moves Tracked Quarterly

Chart-style summary of Soleus Capital Management, L.P.'s 13F portfolio changes for the quarter ending 2026-03-31, showing new positions, increases, and exits across healthcare and biotech stocks.

Soleus Capital Management, L.P. is a healthcare-focused institutional investor whose equity holdings are disclosed each quarter through SEC Form 13F filings. This profile tracks those disclosures over time, giving a running record of the fund’s reported buys, sells, and position size changes as new 13F data becomes available. Because 13F filings only capture a quarterly … Read more